Skip to main content

Table 8 maspin expression in head and neck cancers

From: Role of maspin in cancer

Authors Year N. patients Maspin expression Clinical pathological features/prognosis
Yoshizawa et al. 2011 54 (OSCC) 64.8% positive maspin Positive maspin = 77.8% OS
35.2% negative maspin Negative maspin = 29.4% OS
Yoshizawa et al. 2009 71 (OSCC) 64.8% positive maspin Positive maspin = 100% low grade, 93.3% no lymphnode metastasis, better OS
Iezzi et al. 2007 89 (OSCC) Not found Positive maspin = low grade, negative lymphnode, high stage(?)
Marioni et al. 2008 56 (OSCC) 58.9% positive maspin  
5.3 % positive nucleus  
1.8% positive cytoplasm-nucleus  
51.8% positive cytoplasm Positive cytoplasmic maspin = 61% pN0 and 33% pN+
41.1% negative maspin  
Marioni et al. 2011 68 (laryngeal cancer) Not found Positive nucleus = 22.7% lower recurrence and PFS: 44.5 ± 27.5 months
     Positive cytoplasm and cytoplasm-nucleus = 44.6% longer recurrence and PFS: 34 ± 27.5 months